Medtronic (MDT) Gets Approval from U.S. FDA for MiniMed Paradigm REAL-Time Revel System
Tweet Send to a Friend
Medtronic, Inc. (NYSE: MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
